Literature DB >> 28965985

Dysfunctions of mitochondria in close association with strong perturbation of long noncoding RNAs expression in down syndrome.

Jia-Jun Qiu1, Yan-Na Liu2, Zhao-Rui Ren3, Jing-Bin Yan4.   

Abstract

Trisomy 21 is the most common chromosomal disorder and underlies Down syndrome. Epigenetics, such as DNA methylation and post-translational histone modifications, plays a vital role in Down syndrome. However, the functions of epigenetics-related long noncoding RNAs (lncRNAs), found to have an impact on neural diseases such as Alzheimer's disease, remain unknown in Down syndrome. In this study, we analyzed the RNA sequencing data from Down syndrome-induced pluripotent stem cells (iPSCs) and normal iPSCs. A large number of lncRNAs were identified differentially expressed in Down syndrome-iPSCs. Notably, stronger perturbation was shown in the expression of lncRNAs compared to protein coding genes (Kolmogorov-Smirnov test, P<0.05), suggesting that lncRNAs play more important roles in Down syndrome. Through gene set enrichment analysis and bi-clustering, we also found that most of the differential expressed lncRNAs were closely associated with mitochondrial functions (e.g. mitochondrion organization, P=3.21×10-17; mitochondrial ATP synthesis coupled electron transport, P=1.73×10-19 and mitochondrial membrane organization, P=4.04×10-8). PCR-array and qRT-PCR results revealed that almost all genes related to mitochondria were down-regulated in Down syndrome-iPSCs, implying that mitochondria were dysfunctional in Down syndrome (e.g. ATP5B, Fold Change=-8.2317; COX6A1, Fold Change=-12.7788 and SLC25A17, Fold Change=-22.1296). All in all, our study indicated that a stronger perturbation of lncRNAs expression may lead to the dysfunction of mitochondria in Down syndrome.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Down syndrome; Long noncoding RNAs (lncRNAs); Mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28965985     DOI: 10.1016/j.biocel.2017.09.017

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

Review 1.  The Emerging Roles of Long Non-Coding RNAs in Intellectual Disability and Related Neurodevelopmental Disorders.

Authors:  Carla Liaci; Lucia Prandi; Lisa Pavinato; Alfredo Brusco; Mara Maldotti; Ivan Molineris; Salvatore Oliviero; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

2.  Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndrome.

Authors:  Romina B Cejas; Jie Wang; Rachael Hageman-Blair; Song Liu; Javier G Blanco
Journal:  Gene       Date:  2020-08-27       Impact factor: 3.913

3.  Cis-acting: A pattern of lncRNAs for gene regulation in induced pluripotent stem cells from patients with Down syndrome determined by integrative analysis of lncRNA and mRNA profiling data.

Authors:  Wenbo Ma; Yanna Liu; Houshi Ma; Zhaorui Ren; Jingbin Yan
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

Review 4.  Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein.

Authors:  Wileidy Gomez; Rodrigo Morales; Vinicius Maracaja-Coutinho; Valentina Parra; Melissa Nassif
Journal:  Aging (Albany NY)       Date:  2020-01-09       Impact factor: 5.682

5.  Catechin relieves hypoxia/reoxygenation-induced myocardial cell apoptosis via down-regulating lncRNA MIAT.

Authors:  Lin Cong; Yisheng Su; Dazhen Wei; Lu Qian; Dawei Xing; Jialin Pan; Ye Chen; Mingyuan Huang
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

Review 6.  Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.

Authors:  Carmen Martínez-Cué; Noemí Rueda
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

Review 7.  Mitochondrial Dysfunction: A Common Denominator in Neurodevelopmental Disorders?

Authors:  Xilma R Ortiz-González
Journal:  Dev Neurosci       Date:  2021-08-03       Impact factor: 3.421

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.